Susceptibility surveillance of U.S. respiratory pathogen isolates to newer macrolide and azalide antibiotics

International Journal of Antimicrobial Agents

Volumn 7, Issue 1, 1996, Pages 53-58

  Brown, S ^a   Barry, A L ^a   Burton, P ^b  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

^b Microbiology Reference Laboratory   (United States)

Author keywords

Azithromycin; Respiratory pathogens; Susceptibility

Indexed keywords

AZITHROMYCIN; BETA LACTAMASE; CLARITHROMYCIN; MACROLIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; UNITED STATES;

EID: 0029942080     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-8579(96)00010-6     Document Type: Article

References (20)

1. Bright GM, Nagel AA, Bordner J et al. Synthesis, in vitro and in vivo activity of novel 9-deoxy-9a-aza-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. J Antibiotics (Tokyo) 1988;41:1029-1047.
2. Kirst HA, Sides GD. New directions for macrolide antibiotics: structural modifications and in vitro activity. Antimicrob Agents Chemother 1989;33:1413-1418.
3. Bahal N, Nahata C. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin and roxithromycin. Ann Pharmacother 1992;26:46-55.
4. Barry AL, Jones RN, Thornsberry C. In vitro activities of azithromycin (CP 62,993) clarithromycin (A-56268; TE-031), erythromycin, roxithromycin and clindamycin. Antimicrob Agents Chemother 1988;32:752-754.
5. Retsema J, Girard A, Schelkly W et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrob Agents Chemother 1987;31:1939-1947
6. Maskell JP, Sefton AM, Williams JD. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes. J Antimicrob Chemother 1990;25 (suppl A):19-24.
7. Williams JD. Spectrum of activity of azithromycin. Eur J Clin Microbiol Infect Dis 1991;10:813-820.
8. Hardy DJ, Hensey DM, Beyer JM, Vojtko C, McDonald EJ, Fernandes PB. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 1988;32:1710-1719.
9. Goldstein FW, Emirian MF, Coutrot A, Acar JF. Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae. J Antimicrob Chemother 1990;25(suppl A):25-28.
10. National committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 2nd edition. Approved Standard NCCLS Document M7-A2, Vol. 10, No. 8 NCCLS, Villanova, PA, 1990.
11. O'Callaghan CH, Morris A, Kirby SM, Shingler SH. Novel method for detecting β-lactamase by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972;1:283-288.
12. Barry AL, Fuchs PC, Brown SD. Relative potencies of azithromycin, clarithromycin and five other orally administered antibiotics. J Antimicrob Chemother 1995;35:552-553.
13. George MJ, Kitch B, Henderson FW, Gilligan PH. In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center. Antimicrob Agent Chemother 1991; 35:1960-1964.
14. Jacobs NF Jr, Jerris RC. Haemophilus influenzae resistance in a community hospital. South Med J 1991;84:730-732.
15. Scriver SR, Walmsley SL, Kau CL et al. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamases. Canadian Haemophilus Study Group. Antimicrob Agents Chemother 1994;38:1678-1680.
16. Ringertz S, Muhe L, Krantz I et al. Prevalence of potential respiratory disease bacteria in children in Ethiopia. Antimicrobial susceptibility of the pathogens and use of antibiotics among the children. Acta Paediatrica 1993;82:843-848.
17. Perea EJ, Garcia, Clavijo MJ et al. Resistance in Haemophilus influenzae in Spain. 2nd study, 1990. Enferm Infecc Microbiol Clin 1993;11:19-28.
18. Cullmann W. Importance of β-lactamase stability in treating today's respiratory tract infections. Respiration 1993;63(suppl 1):10-15.
19. Sehgal SC, al Shaimy I. Moraxella catarrhalis in upper respiratory tract of healthy Yemeni children/adults and paediatric patients: detection and significance. Infection 1994;22:193-196.
20. Fung CP, Powell M, Seymour A, Yuan M, Williams JD. The antimicrobial susceptibility of Moraxella catarrhalis isolated in Scotland in 1991. J Antimicrob Chemother 1992;30:47-55.